solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - imunosupresivi - molimo pogledajte odjeljak 4. 1 sažetak značajki proizvoda u dokumentu o informacijama o proizvodu.
cyltezo
boehringer ingelheim international gmbh - adalimumab - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - imunosupresivi - molimo pogledajte odjeljak 4. 1 sažetak značajki proizvoda u dokumentu o informacijama o proizvodu.
humira 40 mg/0.8 ml otopina za injekciju
abbvie d.o.o. - adalimumab - otopina za injekciju - 40 mg/0.8 ml - 0,8 ml otopine za injekciju sadrži: 40 mg adalimumaba
humira 40 mg/0.4 ml rastvor za injekciju u napunjenoj šprici
abbvie d.o.o. - adalimumab - rastvor za injekciju u napunjenoj šprici - 40 mg/0.4 ml - 0,4 ml rastvora za injekciju u napunjenoj šprici sadrži: 40 mg adalimumaba
nordimet
nordic group b.v. - metotreksat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastična sredstva - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
teriflunomid abdi 14 mg filmom obložene tablete
abdi pharma gmbh, donnersbergstrasse 4, heppenheim (bergstrasse), hesse, njemačka - teriflunomid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 14 mg teriflunomida
teruma 14 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - teriflunomid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 14 mg teriflunomida
olumiant
eli lilly nederland b.v. - baricitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant se može koristiti kao monoterapija ili u kombinaciji s metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
metotreksat zentiva 100 mg/ml otopina za injekciju/infuziju
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - metotreksat - otopina za injekciju / infuziju - 100 mg/ml - urbroj: jedna bočica s 10 ml otopine sadrži 1000 mg metotreksata (100 mg/ml)
metotreksat zentiva 2,5 mg/ml otopina za injekciju/infuziju
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - metotreksat - otopina za injekciju / infuziju - 2,5 mg/ml - urbroj: jedna bočica s 2 ml otopine sadrži 5 mg metotreksata (2,5 mg/ml)